Identification of mineralocorticoid receptor target genes in the mouse hippocampus by Weert, L.T.C.M. van et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/208000
 
 
 
Please be advised that this information was generated on 2020-09-10 and may be subject to
change.
Journal of Neuroendocrinology. 2019;31:e12735.	 	 	 | 	1 of 12
https://doi.org/10.1111/jne.12735
wileyonlinelibrary.com/journal/jne
 
Received:	19	December	2017  |  Revised:	10	May	2019  |  Accepted:	10	May	2019
DOI: 10.1111/jne.12735  
O R I G I N A L  A R T I C L E
Identification of mineralocorticoid receptor target genes in the 
mouse hippocampus
Lisa T. C. M. van Weert1,2,3  |   Jacobus C. Buurstede1 |   Hetty C. M. Sips1 |   
Sabine Vettorazzi4 |   Isabel M. Mol1 |   Jakob Hartmann5 |   Stefan Prekovic6 |   
Wilbert Zwart6 |   Mathias V. Schmidt7 |   Benno Roozendaal2,3 |   Jan P. Tuckermann4 |    
R. Angela Sarabdjitsingh8 |   Onno C. Meijer1
This	is	an	open	access	article	under	the	terms	of	the	Creat	ive	Commo	ns	Attri	bution	License,	which	permits	use,	distribution	and	reproduction	in	any	medium,	
provided the original work is properly cited.
©	2019	The	Authors.	Journal of Neuroendocrinology	published	by	John	Wiley	&	Sons	Ltd	on	behalf	of	British	Society	for	Neuroendocrinology
van	Weert	and	Buurstede	contributed	equally.	
1Einthoven	Laboratory,	Division	
of	Endocrinology,	Department	of	
Medicine,	Leiden	University	Medical	Center,	
Leiden,	The	Netherlands
2Department of Cognitive 
Neuroscience,	Radboud	University	Medical	
Center,	Nijmegen,	The	Netherlands
3Donders	Institute	for	Brain,	Cognition	and	
Behaviour,	Radboud	University,	Nijmegen,	
The	Netherlands
4Institute	of	Comparative	Molecular	
Endocrinology,	University	of	Ulm,	Ulm,	Germany
5Department	of	Psychiatry,	Harvard	
Medical	School,	McLean	Hospital,	Belmont,	
Massachusetts
6Division	of	Oncogenomics,	Oncode	
Institute,	The	Netherlands	Cancer	Institute,	
Amsterdam,	The	Netherlands
7Department	of	Stress	Neurobiology	and	
Neurogenetics,	Max	Planck	Institute	of	
Psychiatry,	Munich,	Germany
8Department of Translational 
Neuroscience,	UMC	Utrecht	Brain	
Center,	University	Medical	Center,	Utrecht,	
The	Netherlands
Correspondence
Onno	C.	Meijer,	Division	of	Endocrinology,	
Department	of	Medicine,	Leiden	University	
Medical	Center,	2300	RC	Leiden,	The	
Netherlands.
Email: o.c.meijer@lumc.nl
Funding information
NWO	ALW	Grant,	Grant/Award	Number:	
823.02.002;	COST	Action	ADMIRE,	Grant/
Award	Number:	BM1301;	Deutsche	
Forschungsgemeinschaft,	Grant/Award	
Number:	CRC1149/C02	INST	40/492‐1
Abstract
Brain	mineralocorticoid	receptors	(MRs)	and	glucocorticoid	receptors	(GRs)	respond	
to the same glucocorticoid hormones but can have differential effects on cellular 
function.	Several	lines	of	evidence	suggest	that	MR‐specific	target	genes	must	exist	
and might underlie the distinct effects of the receptors. The present study aimed to 
identify	MR‐specific	target	genes	in	the	hippocampus,	a	brain	region	where	MR	and	
GR	are	co‐localised	and	play	a	role	in	the	stress	response.	Using	genome‐wide	bind‐
ing	of	both	receptor	types,	we	previously	identified	MR‐specific,	MR‐GR	overlapping	
and	GR‐specific	putative	target	genes.	We	now	report	altered	gene	expression	levels	
of	such	genes	in	the	hippocampus	of	forebrain	MR	knockout	(fbMRKO)	mice,	killed	
at the time of their endogenous corticosterone peak. Of those genes associated with 
MR‐specific	binding,	the	most	robust	effect	was	a	50%	reduction	in	Jun dimerization 
protein 2	(Jdp2)	mRNA	levels	in	fbMRKO	mice.	Down‐regulation	was	also	observed	
for	the	MR‐specific	Nitric oxide synthase 1 adaptor protein	(Nos1ap)	and	Suv3 like RNA 
helicase	(Supv3 l1).	Interestingly,	the	classical	glucocorticoid	target	gene	FK506 bind‐
ing protein 5	 (Fkbp5),	which	 is	associated	with	MR	and	GR	chromatin	binding,	was	
expressed	at	substantially	lower	levels	in	fbMRKO	mice.	Subsequently,	hippocampal	
Jdp2	was	confirmed	to	be	up‐regulated	in	a	restraint	stress	model,	posing	Jdp2 as a 
bona	fide	MR	target	 that	 is	also	responsive	 in	an	acute	stress	condition.	Thus,	we	
show	that	MR‐selective	DNA	binding	can	reveal	functional	regulation	of	genes	and	
further	identify	distinct	MR‐specific	effector	pathways.
K E Y W O R D S
glucocorticoids,	Jdp2,	mineralocorticoid	receptor	knockout,	restraint	stress,	transcription
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1  | INTRODUC TION
Endogenous glucocorticoid hormones affect brain function via two 
closely‐related	 nuclear	 receptors:	 the	 mineralocorticoid	 receptor	
(MR)	and	the	glucocorticoid	receptor	(GR).	The	ligand	concentration	
in	part	determines	the	specific	MR/GR	responses.	High	affinity	MRs	
are occupied by endogenous corticosteroids under basal conditions 
and have been found to be more relevant in the initial phase of a 
stress response.1,2	By	contrast,	the	lower	affinity	GRs	are	activated	
only	at	higher	glucocorticoid	levels,	around	the	peak	of	the	circadian	
rhythm	and	during	a	stress	response.	Although	GRs	are	expressed	
widely	throughout	the	central	nervous	system,	brain	glucocorticoid	
binding	MRs	are	mainly	restricted	to	limbic	areas.3
In	the	hippocampus,	MR	and	GR	are	crucial	for	spatial	memory	
and	the	modulation	of	cognition,	mood	and	behaviour.3 Within the 
CA1	hippocampal	 subregion,	MR	and	GR	mediate	opposite	 gluco‐
corticoid	 effects	 on	 pyramidal	 neurone	 excitability4 via transcrip‐
tional mechanisms.5	Also,	spatial	learning	in	rodents	is	differentially	
affected	by	MR	and	GR	signalling,	with	MR	modulating	response	se‐
lection	and	GR	being	essential	for	memory	consolidation.6,7	Because	
of	intrinsic	MR‐mediated	effects	that	oppose	those	of	GR,	it	has	long	
been	 argued	 that	MR‐specific	 target	 genes	must	 exist.8	 The	 exis‐
tence	 of	MR‐specific	 transcriptional	 coregulators9,10 also supports 
this	idea.	However,	many	of	the	effects	that	can	be	attributed	spe‐
cifically	to	MR	function	so	far	comprise	rapid	non‐genomic	effects,	
mediated by the membrane variant of the receptor.11,12
Several	 classical	 genomic	 MR‐targets	 have	 been	 described	 in	
various	 tissues	 over	 the	 past	 two	decades,	 such	 as	FK506 binding 
protein 5	(Fkbp5),13 glucocorticoid‐induced leucine zipper	(Gilz),14 period 
circadian clock 1	(Per1)15 and serum/glucocorticoid regulated kinase 1 
(Sgk1).16	However,	 these	genes	are	all	known	to	be	GR	responsive	
as well.17‐20	Of	note,	not	only	can	the	two	receptors	bind	their	tar‐
get	DNA	as	homodimers,	but	also	heterodimerisation	of	MR/GR	has	
been described.15	Although	MR‐selective	transrepression	and	trans‐
activation	may	occur,21,22	to	date,	no	hippocampal	genomic	targets	
have	been	reported	that	are	strictly	MR‐dependent.	Transcriptional	
changes	have	been	attributed	to	MR	function,23 although they were 
not formally proven to be direct targets of the receptor and might 
thus	 be	 affected	 by	MR	 activity	 in	 an	 indirect	 manner.	 However,	
although	 the	 presence	 of	 glucocorticoid	 response	 element	 (GRE)	
appears	to	be	crucial	for	both	MR	and	GR	DNA	binding	in	the	hippo‐
campus,	binding	sites	for	NeuroD	transcription	factors	were	found	
selectively	at	MR‐bound	loci.24	NeuroD	factors	could	coactivate	glu‐
cocorticoid‐induced	 transactivation	and	were	 indeed	present	near	
MR‐specific	binding	sites,	 suggesting	 that	specific	GRE‐dependent	
MR	target	genes	do	exist.
The	 present	 study	 investigated	whether	 direct	MR	 binding	 to	
the	 hippocampal	DNA	 led	 to	 expression	 regulation	 of	 the	 nearby	
gene.	Based	on	our	 recent	work	 that	defined	MR‐specific,	MR‐GR	
overlapping	and	GR‐specific	chromatin	binding	sites	and	the	corre‐
sponding	 putative	 target	 genes	within	 the	 rat	 hippocampus,24 we 
examined	mRNA	levels	of	several	genes	in	each	of	these	categories.	
Forebrain	MR	knockout	(fbMRKO)	mice	showed	altered	expression	
for	a	subset	of	genes,	including	down‐regulation	of	the	mixed	MR/
GR	 target	Fkbp5,	 as	well	 as	MR‐specific	 Jun dimerization protein 2 
(Jdp2),	Nitric oxide synthase 1 adaptor protein	 (Nos1ap)	and	Suv3 like 
RNA helicase	 (Supv3 l1)	mRNA	 levels.	Subsequently,	corticosterone	
responsiveness of Jdp2,	which	is	one	of	the	genes	with	an	MR‐bound	
promoter,	was	validated	in	mice	that	were	exposed	to	different	du‐
rations of restraint stress.
2  | MATERIAL S AND METHODS
2.1 | Animals
Male	homozygous	 fbMRKO	and	control	c57bl/6	mice	 (n	=	7)	aged	
8‐9	 weeks	 were	 housed	 under	 a	 12:12	 hour	 light/dark	 reversed	
photocycle	 (lights	off	9.00	am).	The	fbMRKO	mice	were	generated	
using	MRflox	mice,	with	MR	exon	3	flanked	by	loxP	sites,	and	mice	ex‐
pressing	Cre	recombinase	controlled	by	the	CAMKIIα gene.25	Male	
MRflox/floxCamKCreCre/wt	mice	were	 crossed	with	 female	MRflox/flox 
mice	to	generate	fbMRKO	(MRflox/flox_Cre)	and	control	(MRflox/flox_wt)	
offspring.	Because	the	breeding	unexpectedly	generated	more	fb‐
MRKO	than	control	mice,	only	part	of	the	control	animals	were	lit‐
termates.	No	differences	were	found	in	expression	levels	between	
littermate	 and	non‐littermate	 controls	 for	 any	of	 the	 genes	meas‐
ured.	 Mice	 were	 transferred	 to	 a	 novel	 cage	 20	 minutes	 before	
harvesting the tissue and then killed around the time of their en‐
dogenous	corticosterone	peak,	between	9.30	am and 12.00 pm. We 
assessed	the	expression	of	MR,	overlapping	and	GR	putative	target	
genes in this condition because both receptor types are activated 
at peak of the diurnal corticosterone rhythm. The novel cage was 
included	in	the	protocol	to	ensure	MR	and	GR	binding	for	chroma‐
tin	 immunoprecipitation	(ChIP)	analysis	 in	the	same	animals,	under	
the	assumption	that	mRNA	levels	will	not	be	affected	in	this	short	
time span. Trunk blood was collected from all mice and hippocampal 
hemispheres	were	freshly	dissected	and	snap‐frozen	in	liquid	nitro‐
gen for later analysis.
For validation of Jdp2	down‐regulation,	male	 fbMRKO	 (n	=	14)	
and	littermate	controls	(n	=	10)	aged	8‐12	weeks	were	housed	under	
a	 12:12	 hour	 light/dark	 photocycle	 (lights	 on	 7.00	 am).	Mice	were	
bred	as	described	above.	Mice	were	killed	under	baseline	conditions,	
between 9.30 am and 10.30 am.	Brains	were	collected	and	snap‐fro‐
zen	in	liquid	nitrogen	for	later	analysis.
For	MR	binding	site	validation	in	the	mouse	brain,	male	c57bl/6	
mice	 (n	 =	 5)	 aged	 16‐19	weeks	were	 housed	 under	 a	 12:12	 hour	
light/dark	photocycle	(lights	on	8.00	am)	and	were	killed	in	the	after‐
noon 60 minutes after an i.p. injection of 3.0 mg kg‐1 corticosterone 
(Sigma,	St	Louis,	MO,	USA)	dissolved	in	5%	ethanol	in	saline,	ensur‐
ing	MR	binding.	Hippocampal	hemispheres	were	 freshly	dissected	
and	snap‐frozen	in	liquid	nitrogen	for	later	analysis.
Male	Balb/c	mice	(n	=	3‐6)	aged	8‐15	weeks	were	housed	under	
a	 12:12	 hour	 light/dark	 photocycle	 (lights	 on	 6.00	 am)	 and	 were	
exposed	 to	 various	periods	of	 restraint	 stress	 (0,	 30,	 60,	 120	 and	
240	minutes)	 and	killed	directly	 afterwards,	 between	9.30	am and 
2.00 pm.	At	this	time	of	the	diurnal	corticosterone	trough,	both	MR	
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TA B L E  1  Primer	sequences	used	for	a	quantitative	polymerase	chain	reaction	in	mouse	hippocampal	chromatin	immunoprecipitation	
samples	(for	binding	site	details,	see	Table	3)
Binding site Nearest gene Forward and reverse (5′‐ to 3′)
Product 
length (bp)
GR3000_1726 Acsl6 CCTGCCAGGAGAGCAGATGTGTGCAGGAAGGCAAGTTCT 178
MR3000_740GR3000_34 Fkbp5 TGCCAGCCACATTCAGAACATCAAGTGAGTCTGGTCACTGC 122
MR3000_1054 Jdp2 AAGTAAGACCGCGACCTACAAAATACCCAGTGCAGAGACGAA 192
MR300_473GR3000_599 Kif1c GCTGGGGTGTACACAGATGGTGACTAGCCAGAGCAGTATGTC	 156
GR3000_106 Mrpl48 AGCTGTGCTTTGGAAGCCTACATAAGGTGGGCCACACTCC	 170
MR300_196 Nos1ap CCTCCGATGCTGCTTGGATACAGACCGAGCCAGCGATAAG	 197
MR3000_738GR3000_12 Per1 GGAGGCGCCAAGGCTGAGTGCGGCCAGCGCACTAGGGAAC 73
MR300_503 Rilpl1 CAGGCAGATGCCAGGCTCCCATGCCTGTTCCTCTAGT	 106
MR3000_359 Supv3 l1 TGCAGGGATTCGATGGACAGCTCTGAGCCACCTCTCAAGC	 165
MR3000_641GR3000_1603 Zfp219 AGTCCATCACATTCTGTTGCTTTCTAGTCAGCTATGACCATGCAGT	 131
TA B L E  2  Primer	sequences	used	for	a	quantitative	real‐time	polymerase	chain	reaction	in	the	mouse	hippocampus
Gene Full name Forward and reverse (5′‐ to 3′)
Product length 
(bp)
Acsl6 Acyl‐CoA	synthetase	long‐chain	
family member 6
TCTCAGGGAATGGACCCTGTCCTCTTGGTAGGACAGCCAC	 135
Bhlhb9 Basic	helix‐loop‐helix	domain	
containing,	class	B9
AACTCACCTGGCCAGCAATCCTCTGGCTGCCTTGGGATTT	 187
C4ST1 (Chst11) Chondroitin	4‐sulfotransferase	1 GAATTTGCCGGATGGTGCTGAGCAGATGTCCACACCGAAG	 117
Camk1d Calcium/calmodulin‐dependent	
protein kinase ID
GCATCGAGAACGAGATTGCCCCAGACACAAGTTGCATGACC	 114
Camkk2 Calcium/calmodulin‐dependent	
protein kinase kinase 2
AGAACTGCACACTGGTCGAGACCAGGATCACAGTTGCCAG	 85
Fkbp5 FK506	binding	protein	5 TCCTGGGAGATGGACACCAATTCCCGTACTGAATCACGGC	 113
Gilz (Tsc22d3) Glucocorticoid‐induced	leucine	
zipper
TGGCCCTAGACAACAAGATTGAGCCCACCTCCTCTCTCACAGCAT	 78
Hsd17b11 Hydroxysteroid	(17‐β)	dehydroge‐
nase 11
CGCAGGACCCTCAGATTGAAGGAGCAGTAAGCCAGCAAGA	 167
Jdp2 Jun	dimerization	protein	2 TACGCTGACATCCGCAACATCGTCTAGCTCACTCTTCACGG	 100
Kif1c Kinesin	family	member	1C TTAATGCCCGTGAGACCAGCAAGCTTTTGGGGGCATCCTT	 106
Mrpl48 Mitochondrial	ribosomal	protein	
L48
CAGTATGTCCACCGCCTCTGCTCGCTCATGGGTGGTAAGG	 145
Nos1ap Nitric	oxide	synthase	1	adaptor	
protein
TGGAATTCAGCCGAGGTGTGGGAAGGGAGCAGCATTCGAG	 131
Nr3c1	(GR) Nuclear	receptor	subfamily	3,	
group	C,	member	1
CCCTCCCATCTAACCATCCTT	ACATAAGCGCCACCTTTCTG	 89
Nr3c2	(MR) Nuclear	receptor	subfamily	3,	
group	C,	member	2
TCCAAGATCTGCTTGGTGTGCCCAGCTTCTTTGACTTTCG 239
Per1 Period circadian clock 1 ACGGCCAGGTGTCGTGATTACCCTTCTAGGGGACCACTCA	 162
Rilpl1 Rab	interacting	lysosomal	protein‐
like 1
ACGAGCTCAAGTCCAAGGTGAGTCGCTTGATCCCCGATTC	 148
Rplp0 Ribosomal	protein,	large,	P0 GGACCCGAGAAGACCTCCTTGCACATCACTCAGAATTTCAATGG 85
Sgk1 Serum/glucocorticoid regulated 
kinase 1
AGAGGCTGGGTGCCAAGGATCACTGGGCCCGCTCACATTT	 129
Supv3 l1 Suv3	like	RNA	helicase CTCACTCGGCCTCTAGACAAGTCCACGTCCAGAGAATGGGA	 170
Zfp219 Zinc finger protein 219 GATCTGCAGCGCTACTCCAATGCACGAGTCTCAGACCAAC	 96
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and	GR	DNA	binding	can	be	enhanced	in	response	to	stress15 and 
consequential	gene	expression	changes	compared	to	non‐stressed	
control mice could be revealed. Trunk blood was collected from 
all	mice,	and	hippocampal	hemispheres	were	freshly	dissected	and	
snap‐frozen	in	liquid	nitrogen	for	later	analysis.
All	 experiments	 were	 performed	 in	 accordance	 with	 the	
European	Commission	Council	Directive	2010/63/EU	and	the	Dutch	
law	on	animal	experiments	and	approved	by	the	animal	ethical	com‐
mittee	 from	 Utrecht	 University,	 University	 of	 Amsterdam,	 or	 the	
German	Regierungspräsidium	Tübingen.
2.2 | Plasma measurements
Trunk blood was centrifuged for 10 minutes at 7000 g,	after	which	
plasma was transferred to new tubes. Corticosterone levels of 
the	 fbMRKO	 experiment	 were	 determined	 using	 an	 enzyme	 im‐
munoassay	 (Immunodiagnostic	 Systems,	 East	 Boldon,	 UK)	 and	
adrenocorticotrophic	hormone	(ACTH)	and	corticosterone	levels	of	
the	restraint	stress	mice	were	determined	using	an	enzyme‐linked	
immunosorbent	assay	(IBL	International,	Hamburg,	Germany)	in	ac‐
cordance with the manufacturers’ instructions.
2.3 | Target gene selection
MR‐specific,	 MR‐GR	 overlapping	 and	 GR‐specific	 binding	 sites	
were annotated to the nearest gene.24 To increase the chances of 
correct	annotation	and	 identifying	 functional	 target	genes,	we	 fo‐
cused	 on	 binding	 sites	 located	 intragenic	 or	 in	 the	 proximal	 pro‐
moter	 (up	 to‐5	kb).	 Furthermore,	hippocampal	 expression26 of the 
putative	target	genes,	the	degree	of	coexpression	with	NeuroD	fac‐
tors	(Neurod1/2/6)	and	face	validity	of	ChiP‐sequencing	(ChIP‐seq)	
peaks were assessed. The total numbers of putative target genes 
measured	 for	MR‐specific,	 overlapping	 (including	 classical	 targets)	
and	GR‐specific	subset	were	12,	10	and	9,	respectively.
TA B L E  3   Selected putative target 
genes to validate
Additional	binding	site	information	can	be	found	in	the	supplemental	data	of	van	Weert	et	al.24
Yellow:	MR	specific	loci;	Green:	Mixed	MR/GR	loci;	Blue:	GR	specific	loci.
Sequences	represent	the	rat	glucocorticoid	response	element	(GRE)	(upper)	and	mouse	GRE	
(lower)	with	mismatches	to	the	rat	sequence	indicated	in	red.
ABA,	Allen	Brain	Atlas	(http://mouse.brain‐map.org/);	TSS,	transcription	start	site.
Binding site GRE sequence (rat/mouse) Annotation 
Distance from 
TSS (bp) 
Associated 
gene 
ABA hippocampal 
expression 
MR300_225 AGAACATTATGTTCC AAAACATCAGGATCC Intron 116761 Camkk2 10.34 
MR3000_360 GGAACACTCTCTTCC GGAACTCTCTCTTCC Intergenic –1071 Hsd17b11 3.98 
MR3000_1054 AGAGCTCTTTGTGTT AGAATTCTTTGTGTT Intergenic –3983 Jdp2 13.58 
MR300_196 CTCACACTTTCTCCC CTAGCACTCTCTCCC Intron 233500 Nos1ap 11.50 
MR300_503 CAACCTCTTTCTTCC CAACCCTCTTTCTCC Intron 12715 Rilpl1 15.52 
MR3000_359 TGTGCTTTCTGTTCC GGTGCTTTTTGTTAC Intron 1661 Supv3l1 0.83 
MR300_713 
GR3000_248 
AGAGCAGGCTGTTCT 
AAAACAGCCTGGTCT Intron 95108 Camk1d 
2.64 
(mainly CA) 
MR3000_740 
GR3000_34 
AGAACAGGGTGTTCT 
AGAACAGGGTGTTCT Intron 62931 Fkbp5 8.86 
MR300_473 
GR3000_599 
GGGACTGGAAGTTCC 
GGAACTTCCAGTCCC Intron 9921 Kif1c 2.94 
MR3000_738 
GR3000_12 
GGAACATCGTGTTCT 
GGAACATCGTGTTCT Intergenic –3357 Per1 3.06 
MR3000_641 
GR3000_1603 
ACACCAGGATGTTCC 
ACACCAGGATGTTCC Intergenic –2125 Zfp219 2.62 
GR3000_1726 TGAACTTGCAGCGTT TGAGCTTGCAGCATT Intergenic –1931 Acsl6 15.52 
GR3000_647 AGGACTGTTAGTACT AGGGCTTTTAGTACT Intergenic –3526 Bhlhb9 9.05 
GR3000_193 AGAACTGTCTGCACC AGAACTCTCCATCAG Intron 121265 C4ST1 7.28 
GR3000_106 GGCTCTCCTTGTGCT GACTGTCCTTGTGCC Intron 24445 Mrpl48 4.71 
 
F I G U R E  1  Validation	of	mineralocorticoid	receptor	(MR)	detection	in	wild‐type	(WT)	mice	and	absence	of	MR	in	forebrain	MR	
knockout	(fbMRKO)	mice.	(A)	Hippocampal	mRNA	levels	showing	MR	down‐regulation	and	slight	GR	up‐regulation,	as	well	as	(B)	unaltered	
plasma	corticosterone	levels	in	fbMRKO	vs	WT	mice,	as	assessed	by	independent	t‐tests.	(C)	MR	binding	assessed	by	a	chromatin	
immunoprecipitation‐quantitative	polymerase	chain	reaction	in	the	hippocampus	of	WT	mice,	along	with	an	immunoglobulin	(Ig)G	
background	signal	per	sample,	as	assessed	by	one‐tailed	paired	t‐tests.	Corresponding	measurements	are	depicted	in	the	same	colour.	GR‐
specific targets Acsl6 and Mrpl48 served as negative controls; classical glucocorticoid targets Fkbp5 and Per1	served	as	positive	controls.	a.u.,	
arbitrary unit. *P < 0.05,	**P < 0.01,	****P < 0.0001
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2.4 | ChIP‐quantitative polymerase chain reaction 
(PCR)
For	MR	binding	validation	in	the	mouse,	we	performed	ChIP‐quan‐
titative	PCR	on	hippocampal	tissue	of	wild‐type	 (WT)	mice	 (n	=	5)	
as described previously.27	Hippocampal	hemispheres	were	cryosec‐
tioned at 30 μm	before	cross‐linking	with	2	mmol	L‐1 disuccinimidyl 
glutarate,	 followed	 by	 1%	 formaldehyde.	 Fixated	 tissue	 was	 sus‐
pended,	nuclei	were	 isolated	and	sonicated	for	10	rounds	 (30	sec‐
onds	 ON/30	 seconds	 OFF)	 using	 a	 Bioruptor	 Pico	 (Diagenode,	
Seraing,	Belgium).	Chromatin	of	two	hemispheres	of	the	same	animal	
was	pooled	and	used	for	a	single	ChIP	sample	(500	μL)	to	measure	
MR	binding	with	5	μg	of	anti‐MR	antibody	(21854‐1‐AP;	ProteinTech,	
Rosemont,	IL,	USA).	Immunoprecipitation	was	performed	with	50	μL	
of	magnetic	Protein	A	beads	(Dynabeads;	Invitrogen,	Carlsbad,	CA,	
USA).	The	background	signal	was	detected	for	each	sample	with	a	
sequential	ChIP	using	5	μg	of	control	immunoglobulin	(Ig)G	antibody	
(ab37415;	Abcam,	Cambridge,	MA,	USA).	Pellets	were	dissolved	 in	
50 μL	10	mmol	L‐1	Tris‐HCl	(pH	8).	Subsequently,	a	quantitative	PCR	
was	performed	on	5	×	diluted	ChIP	samples,	with	primers	that	were	
designed	to	span	the	GRE	of	the	MR	binding	sites	(Table	1).
2.5 | Real‐time quantitative PCR
Mouse	hippocampal	hemispheres	were	homogenised	in	TriPure	(Roche,	
Basel,	Switzerland)	by	shaking	the	tissue	with	1.0‐mm	diameter	glass	
beads for 20 seconds at 6.5 m s‐1	in	a	FastPrep‐24	5G	instrument	(MP	
Biomedicals,	Santa	Ana,	CA,	USA).	Total	RNA	was	isolated,	cDNA	was	
generated	and	quantitative	real‐time	PCR	was	performed	as	described	
previously.24	Because	Actb	(β‐actin)	expression	was	regulated	between	
fbMRKO	and	control	mice,	genes	of	interest	were	normalised	against	
the	 in	both	experiments	stably	expressed	housekeeping	gene	Rplp0,	
encoding	a	ribosomal	protein.	Primer	sequences	are	listed	in	Table	2.
2.6 | In situ hybridisation
Frozen	 brains	 were	 sectioned	 at	 18	 μm	 in	 a	 cryostat	 microtome,	
collected	on	SuperFrost	Plus	 slides	 (Thermo	Scientific,	Walthaqm,	
MA,	USA)	and	stored	at	−80°C	until	 further	use.	 In	situ	hybridisa‐
tion using 35S	UTP‐labelled	ribonucleotide	probes	for	Jdp2 was per‐
formed as described previously.28
2.7 | Statistical analysis
In	 the	 fbMRKO	 experiment,	 independent	 t‐tests	 were	 used	 and	
P < 0.01	 was	 considered	 as	 a	 statistically	 significance	 cut‐off	 to	
correct	 for	 multiple	 gene	 testing.	 For	 the	 ChIP‐quantitative	 PCR	
validation,	we	performed	one‐tailed	paired	t tests. The predictable 
directionality	(ie,	the	MR	signal	 is	higher	than	the	background	IgG	
signal)	 justifies	the	use	of	a	one‐tailed	test.	Because	a	decrease	in	
signal	might	also	be	relevant,	we	note	that	all	statisitically	significant	
results were at P < 0.025 and therefore would also be significant 
using	 a	 two‐tailed	 test.	We	 considered	 a	 paired	 test	 appropriate	
because	MR	and	IgG	are	measured	on	the	same	chromatin	sample	
and this allows correction for the corresponding background levels. 
Again,	one‐tailed	unpaired	t tests gave essentially the same results. 
For the gene Nos1ap,	one	of	the	samples	was	excluded	from	analysis	
because	of	a	missing	value	as	a	result	of	non‐detectable	IgG	levels.	
For	the	time	course	of	restraint	stress,	a	one‐way	ANOVA	was	per‐
formed	with	Holm–Sidak's	multiple	 comparison	 post‐hoc	 tests.	 In	
the	in	situ	measurements	of	the	fbMRKO	animals,	unpaired	t tests 
were performed. P < 0.05 was considered statistically significantly 
significant unless stated otherwise. prism,	 version	 7	 (GraphPad	
Software	 Inc.,	San	Diego,	CA,	USA)	was	used	to	analyse	the	data.	
All	graphs	show	individual	values	and	data	are	further	depicted	as	
the	mean	±	SEM.
3  | RESULTS
To	explore	the	functional	effects	of	previously	detected	MR/GR	
DNA	binding	(ie,	transcription	regulation),	binding	sites	were	as‐
sociated	with	their	nearest	gene.	This	resulted	in	lists	of	MR‐spe‐
cific,	MR‐GR	overlapping	and	GR‐specific	putative	target	genes.24 
Gene	expression	 levels,	 for	 a	 subset	of	 each	 category	 (Table	3),	
were	measured	in	fbMRKO	mice	at	the	time	of	their	diurnal	cor‐
ticosterone	 peak.	 MR	 mRNA	 expression	 was	 indeed	 abolished	
and	GR	mRNA	was	 slightly	 up‐regulated	 in	 the	 hippocampus	 of	
fbMRKO	mice	 (Figure	1A),	confirming	earlier	 reports.25	MR	pro‐
tein	 levels	 also	 showed	 efficient	 knockdown	 Bonapersona	 V.,	
Damsteegt	R.,	Adams	M.L.,	 van	Weert	L.,	Meijer	O.C.,	 Joëls	M.,	
Sarabdjitsingh	 R.A.(unpublished).	 Furthermore,	 no	 differences	
were found in plasma corticosterone levels of these animals at the 
time	 of	 death	 (Figure	 1B).	 Because	 the	 studied	 target	 loci	were	
originally	detected	in	the	rat	brain,24	we	validated	MR	binding	in	
mice.	ChIP‐quantitative	PCR	confirmed	hippocampal	MR	binding	
at the Jdp2	 (P = 0.0124),	Kif1c	 (P = 0.0087),	Nos1ap	 (P = 0.0172),	
Rilpl1	 (P = 0.0098)	 and	Zfp219	 (P = 0.0049)	 loci	 in	WT	mice,	 al‐
though	 this	 signal	 did	 not	 exceed	 background	 IgG	 levels	 at	 the	
GR‐specific	sites	near	Acsl6	(P = 0.4410)	and	Mrpl48	(P = 0.2142)	
(Figure	1C).	Only	for	Supv3 l1	(P = 0.1784)	were	we	unable	to	de‐
tect	 the	 expected	 MR	 binding.	 Also,	 for	 classical	 target	 genes	
F I G U R E  2  Hippocampal	mRNA	levels	of	glucocorticoid	target	genes	assessed	in	wild‐type	(WT)	and	forebrain	mineralocorticoid	receptor	
(MR)	knockout	(fbMRKO)	mice.	Gene	expression	of	(A)	MR‐specific,	(B)	overlapping	and	(C)	glucocorticoid	receptor	(GR)‐specific	targets	
and	(D)	classical	glucocorticoid	targets	in	fbMRKO	versus	WT	mice,	as	assessed	by	independent	t‐tests	with	P < 0.01 as the statistically 
significant	cut‐off.	Other	genes	measured	but	not	differentially	expressed	between	WT	and	fbMRKO	mice	were:	Adam23, Arl8b, Dgkb, Els1, 
Myo16 and Nob1	as	MR‐specific	targets;	Grb2, Luzp1 and Map1lc3b as overlapping targets; Arntl, B3galt1, Map2k5, Pglyrp1 and Slc3a2	as	GR‐
specific	targets.	a.u.,	arbitrary	unit.	#P < 0.05	(considered	a	trend),	**P < 0.01,	***P < 0.001,	****P < 0.0001
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Fkbp5	 (P = 0.0246)	 and	 Per1	 (P = 0.0066),	 MR	 enrichment	 was	
demonstrated.
Several	MR‐specific	 putative	 targets	 showed	 lower	 expression	
levels	in	the	fbMRKO	compared	to	WT	mice	(Figure	2A).	The	most	ro‐
bust effect was found in the Jdp2	mRNA	levels,	which	were	reduced	
by	 50%	 (P < 0.0001).	 Other	 differentially	 expressed	 genes	 were	
MR‐specific	Nos1ap	 (P = 0.0005)	and	Supv3 l1	 (P = 0.0061),	as	well	
as	MR‐GR	overlapping	Camk1d	(P = 0.0016)	and	Kif1c	(P = 0.0022),	
which	were	also	all	down‐regulated	in	the	fbMRKO	compared	to	WT	
mice	 (Figure	2A,B).	Moreover,	 two	of	 the	GR‐specific	genes,	Acsl6 
(P = 0.0002)	and	Mrpl48	(P = 0.0065),	were	expressed	at	lower	lev‐
els,	and	C4ST1	showed	a	trend	for	lowered	expression	(P = 0.0138)	
(Figure	2C).
Besides	the	brain‐related	putative	MR/GR	target	genes,	we	mea‐
sured	the	expression	of	the	classical	 target	genes	Fkbp5, Gilz, Per1 
and Sgk1	(Figure	2D).	These	genes	are	all	known	to	be	bound	and/
or	regulated	by	both	MR	and	GR,	comprising	our	identified	MR‐GR	
overlapping target subset contained Fkbp5 and Per1	 (Table	 3).	Of	
the	 four	 classical	 targets,	 only	 Fkbp5	 was	 down‐regulated	 in	 fb‐
MRKO	mice,	 reaching	 44%	 of	 the	 levels	 observed	 in	WT	 animals	
(P < 0.0001).
Next,	we	aimed	 to	 show	 regulation	of	 the	 target	 genes	 in	 an	
acute	stress	context.	Even	though	MR	is	substantially	occupied	by	
ligand	under	basal	glucocorticoid	levels,	MR	(and	GR)	DNA	binding	
and	subsequent	transcriptional	effects	can	be	enhanced	by	a	rise	
of corticosterone.15	Hippocampal	gene	expression	was	assessed	in	
mice	that	were	exposed	to	restraint	stress	of	different	durations	
(0,	 30,	 60,	 120	 and	 240	 minutes).	 Plasma	 corticosterone	 levels	
were	increased	after	all	durations	of	restraint	stress,	although	they	
tended	to	return	to	baseline	at	120	and	240	minutes,	in	line	with	
the	 fact	 that	 ACTH	 levels	were	 normalised	 at	 these	 time	 points	
(Figure	3A).
Of	 the	 classical	 glucocorticoid	 target	 genes,	 Fkbp5, Gilz and 
Sgk1	were	up‐regulated	after	60,	120	and	240	minutes	of	restraint	
(Figure	3B).	Per1	 showed	a	transient	 increase,	with	elevated	 levels	
at	30	and	60	minutes,	which	had	declined	again	from	120	minutes	
of	restraint	stress.	Interestingly,	the	MR‐exclusive	target	gene	Jdp2 
that	was	mostly	affected	in	fbMRKO	mice	showed	an	increase	in	re‐
sponse	to	stress	(Figure	3C)	in	those	animals	exposed	to	restraint	for	
60‐240	minutes.	Other	genes	associated	with	MR	and/or	GR	binding	
loci that we had selected for validation did not show transcriptional 
effects	upon	restraint	stress	(Figure	3C).
Finally,	we	confirmed	Jdp2	down‐regulation	measured	by	in	situ	
hybridisation	in	an	independent	experiment	in	fbMRKO	(Figure	4).	In	
the	absence	of	MR,	Jdp2	mRNA	levels	were	decreased	in	the	princi‐
pal	neurones	of	the	dorsal	hippocampus,	as	was	apparent	from	a	sig‐
nificantly	lower	expression	in	the	CA2	(P = 0.0001),	CA3	(P = 0.0357)	
and	 dentate	 gyrus	 (P = 0.0005)	 subregions.	 For	 the	CA1,	 this	 oc‐
curred	at	the	trend	level	(P = 0.0901).
4  | DISCUSSION
Based	on	non‐overlapping	MR‐GR	binding	sites,	we	defined	putative	
MR‐specific	and	GR‐specific	hippocampal	target	genes.	We	identified	
Jdp2	as	a	likely	MR‐specific	transcriptional	target	that	is	both	down‐
regulated	in	fbMRKO	mice	and	up‐regulated	in	response	to	restraint	
stress.	Also,	Nos1ap and Supv3 l1,	two	other	genes	linked	to	MR‐spe‐
cific	binding	sites,	were	expressed	at	a	lower	levels	in	fbMRKO	mice	
but did not change upon restraint stress. Classical glucocorticoid tar‐
get genes Fkbp5, Gilz, Per1 and Sgk1 all responded to restraint stress 
by	 increased	 transcription.	Of	 these	 targets,	 only	Fkbp5 showed a 
substantially	lower	hippocampal	expression	in	the	absence	of	MR.
Both	 technical	 and	 biological	 factors	 could	 explain	 the	 limited	
success	with	respect	to	validating	MR‐specific	genomic	targets.	The	
annotation of binding sites to the nearest gene is not without error be‐
cause it is possible that another neighbouring gene is affected by the 
binding locus assessed. We do not have data on spatial chromatin or‐
ganisation	or	RNA	polymerase	activity	in	the	same	experimental	set‐
up,	which	could	enable	the	proper	linking	of	binding	loci	to	the	actual	
site of transcriptional activity.29 To lower the chance of false positive 
annotations,	we	 focused	on	binding	 sites	 that	were	 located	within	
genes	or	(proximal)	promoter	regions.	However,	even	in	cases	where	
the	putative	target	is	legitimate,	we	might	still	have	false	negative	re‐
sults	regarding	gene	expression	changes.	Because	the	hippocampus	
consists	of	several	subregions	and	various	cell	types,	we	might	not	be	
able	to	detect	MR‐dependent	regulation	that	is	constrained	to	a	sub‐
set	of	hippocampal	cells.	Although	the	ChIP‐seq	signal	can	be	suffi‐
ciently	strong	to	withstand	dilution,	gene	regulation	might	be	diluted	
when	the	average	gene	expression	over	 the	whole	hippocampus	 is	
assessed	because	the	fold	change	in	hippocampal	mRNA	expression	
tends to be modest in response to steroids.30 Despite possible false 
negative	results,	we	were	able	to	find	robust	changes	in	several	MR‐
specific and classical glucocorticoid target genes.
It	is	of	note	that	gene	regulation	by	MR	knockout	and	restraint	
stress	was	validated	in	a	mouse	model,	whereas	the	MR/GR	binding	
loci	were	obtained	from	experiments	in	rats.	We	were	able	to	show	
MR	binding	in	the	mouse	hippocampus	at	five	out	of	six	MR	targets	
originally detected in the rat brain. Evolutionary conservation can 
increase	the	predictive	value	of	functional	GREs.31,32	Moreover,	be‐
cause	brain	MR/GR‐mediated	regulation	is	considered	to	be	part	of	a	
general	adaptive	response,	the	genes	regulated	in	the	rat	would	also	
be	expected	to	be	affected	in	mice.	However,	the	species	difference	
is	an	additional	potential	cause	for	absence	of	mRNA	regulation.
F I G U R E  3  Hippocampal	mRNA	levels	of	glucocorticoid	target	genes	assessed	in	a	restraint	stress	model.	A,	Plasma	adrenocorticotrophic	
hormone	(ACTH)	and	corticosterone	levels	after	different	durations	of	restraint	stress.	B,	Validation	of	time‐dependent	classical	
glucocorticoid	target	gene	activation	upon	restraint	stress.	C,	Gene	expression	of	MR‐specific,	overlapping	and	GR‐specific	targets	after	
different	durations	of	restraint	stress.	All	assessed	by	one‐way	ANOVA	with	Holm‐Sidak's	post‐hoc	tests.	a.u.,	arbitrary	unit.	*P < 0.05,	
**P < 0.01,	****P < 0.0001
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The	fbMRKO	animals	become	MR	deficient	during	embryonic	
development	and	loss	of	MR	protein	is	completed	after	birth.25 In 
the	 present	 study,	 down‐regulated	MR	expression	was	 validated	
and	slight	up‐regulation	of	GR	expression	in	the	hippocampus	was	
observed as described previously.25	It	is	possible	that	MR‐depen‐
dent	 gene	 expression	 is	 normalised	 as	 a	 result	 of	 compensation	
by	GR	or	other	 factors.	We	cannot	exclude	that	such	compensa‐
tory	mechanisms	might	also	affect	expression	of	Jdp2, Nos1ap and 
Supv3 l1	 in	 fbMRKO	 mice.	 Also,	 redundancy	 in	 gene	 regulation	
is	 not	 uncommon	 and,	 although	 complete	 dependence	 of	 target	
genes	to	a	single	transcription	factor	can	occur,33 it is rare in case 
of	MR	and	GR	signalling.	In	addition,	the	binding	of	nuclear	recep‐
tors	 such	 as	 MR	 can	 have	 permissive	 effects	 on	 chromatin	 and	
could	be	necessary	but	not	sufficient	for	transcription.	Indeed,	as	
little	 as	13%	of	GR	binding	 sites	 can	be	 linked	 to	 transcriptional	
activity.34	Thus,	the	lack	of	transcriptional	effects	might	reflect	a	
context	dependency.
To	begin	looking	at	MR	regulation	in	a	relevant	context,	we	chose	
a restraint stress paradigm in WT mice as a more physiological set‐
ting.	Mice	were	stressed	in	the	morning	to	ensure	that	basal	corti‐
costerone	 levels	were	 low,	and	MR	activation	not	necessarily	 fully	
maximal.35 The classical glucocorticoid target genes all responded in 
this	acute	stress	situation	and,	of	the	MR‐specific	targets	identified	
in	fbMRKO	mice,	only	Jdp2	expression	was	affected.	Non‐regulated	
genes	in	the	restraint	stress	experiment	might	still	be	MR‐dependent	
but at a lower EC50,
36	or	in	different	contexts,	including	behavioural	
paradigms	 in	 which	 fbMRKO	 animals	 show	 changed	 phenotypes,	
such	as	working	memory	in	a	radial	maze.25
For	 the	 genes	 associated	 with	 GR‐specific	 chromatin	 bind‐
ing,	Acsl6 and Mrpl48	showed	lower	expression	levels	in	fbMRKO	
mice.	 In	 general,	 the	 effect	 size	 on	 specifically	 GR‐associated	
target	gene	expression	was	less	pronounced.	The	fact	that	these	
GR	targets	are	down‐regulated	and	the	expression	of	GR	itself	is	
slightly	 up‐regulated	 in	 fbMRKO	 mice	 appears	 to	 be	 contradic‐
tory.	However,	this	could	be	a	result	of	indirect	effects	of	MR	de‐
ficiency.	Another	explanation	 is	 that	GR	binding	takes	place	at	a	
negative	GRE,	where	GR	leads	to	repression	(instead	of	activation)	
of the nearby gene.37,38
More	interestingly,	several	overlapping	targets	were	down‐reg‐
ulated	in	fbMRKO	mice:	the	newly	identified	Camk1d and Kif1c,	and	
the classical target Fkbp5.	This	suggests	that	MR	is	needed	for	ex‐
pression	of	these	genes	in	the	hippocampus.	The	GR	compensatory	
up‐regulation	 does	 not	 appear	 to	 prevent	 dysregulation	 of	 these	
combined	target	genes	in	the	absence	of	MR.	It	is	likely	that	heterod‐
imerisation	of	MR	and	GR	is	involved	in	the	regulation	of	overlapping	
binding sites. Fkbp5	expression	was	recently	shown	to	be	modulated	
by	MR‐GR	heterodimers.15 The observation that Fkbp5	expression	is	
lowered	in	fbMRKO	mice	can	represent	functional	consequences	of	
the absence of one of the heterodimerisation partners. Fkbp5 is part 
of	an	ultra‐short	feedback	loop	in	which	it	is	induced	by	glucocorti‐
coids,	whereas,	in	turn,	Fkbp5	prevents	GR	activation.39	Besides	the	
observed	up‐regulation	of	GR	expression	itself,	the	 lowered	Fkbp5 
levels could contribute to a compensatory mechanism by relieving 
the	repression	of	GR	function	to	overcome	the	lack	of	MR	signalling.
Overall,	 the	 Jdp2	 gene	was	 the	most	 robust	MR	 target	 identi‐
fied	 in	 the	present	study.	 Initially,	 Jdp2	was	discovered	as	a	nega‐
tive	 regulator	of	 activator	protein‐1	 (AP‐1)	 function,	 by	dimerising	
to	c‐Jun	and	preventing	transcriptional	effects.40	Later,	it	was	found	
that Jdp2 can also act in a stimulating fashion as a coactivator for the 
progesterone receptor.41	In	this	latter	study,	Jdp2	was	also	shown	to	
have	a	coactivating	effect	on	transactivation	by	GR,	as	confirmed	by	
Garza	et	al.42 We found Jdp2	to	be	a	bona	fide	MR	target.	A	feedfor‐
ward	mechanism	could	be	speculated	in	which	MR	can	increase	Jdp2	
levels,	which,	in	turn,	could	enhance	GR	activity.	A	recent	ChIP‐seq	
study in mouse neuroblastoma cells found the Jdp2 binding motif 
near	 both	MR‐	 and	 GR‐bound	 sites.43	 Besides	 the	 differential	 af‐
finity	of	MR	and	GR	for	their	hormone,	temporal	responses	to	glu‐
cocorticoids could be accounted for by such a feedforward loop. 
Feedforward	models	have	been	described	previously	for	GR44 and 
other nuclear receptors.45,46 It is worth noting that Jdp2 has been 
implicated	 in	 AP‐1	modulation	 during	 fear	 extinction,47 and poly‐
morphisms in the Nos1ap	gene	have	been	 linked	to	post‐traumatic	
stress	 disorder	 and	 depression,48 also demonstrating a functional 
role of these genes in the stress system.
In	 conclusion,	 we	 found	 three	 novel	 hippocampal	MR‐specific	
target	genes,	comprising	Jdp2, Nos1ap and Supv3 l1,	of	which	Jdp2 is 
F I G U R E  4   Validation of hippocampal Jdp2	down‐regulation	in	forebrain	mineralocorticoid	receptor	(MR)	knockout	(fbMRKO)	mice	
compared	to	wild‐type	(WT)	mice,	detected	by	in	situ	hybridisation,	as	assessed	by	unpaired	t‐tests.	Left:	representative	scanned	
autoradiograph	film	per	genotype.	Gene	expression	is	quantified	per	subregion	of	the	hippocampus:	cornu	ammonis	(CA)1,	CA2,	CA3	and	
the	dentate	gyrus	(DG).	a.u.,	arbitrary	unit.	**P < 0.01,	***P < 0.001
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also responsive in an acute stress situation. Dissecting the glucocor‐
ticoid	response	in	MR‐specific,	common	and	GR‐specific	pathways	
will enable us to better understand the stress physiology and patho‐
physiology	of	stress‐related	disorders.
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